Tomosynthesis helps CAD catch lung nodules
Digital tomosynthesis shows promise for improved lung nodule detection compared with chest radiography. It may also improve performance of CAD algorithms for lung nodule detection by eliminating structure overlap that causes many false positives, according to a study presented at the 2005 RSNA meeting.
Digital tomosynthesis shows promise for improved lung nodule detection compared with chest radiography. It may also improve performance of CAD algorithms for lung nodule detection by eliminating structure overlap that causes many false positives, according to a study presented at the 2005 RSNA meeting.
Led by Nariman Majdi Nasab, Ph.D., investigators at Duke University tested automated detection of lung nodules on digital tomosynthesis images using a textural and morphological CAD approach. They developed and tested an algorithm (CAD-T) on five subjects using a commercial CsI/a-Si flat-panel detector and a custom tube mover. Patient exposure was equivalent to a lateral screen-film radiograph.
There were 12 nodules in the five subjects. The CAD-T method detected 11 of 12, which ranged from 4 mm to 21 mm. CAD-T marked an average of seven false positives per subject, mainly due to end-on vessels seen in cross section.
Sensitivity and specificity of the CAD-T method proved comparable to other CAD techniques applied to projection chest radiographs, according to the researchers.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
